Literature DB >> 6609359

Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.

D W Roberts, G L Wolff, W L Campbell.   

Abstract

Whereas genetic factors are known to influence both susceptibility to carcinogens and the capacity to respond to specific antigenic stimuli, little is known regarding the influence of phenotype per se. With this in mind, we utilized (YS x VY)F1 hybrid mice consisting of genetically identical (Avy/a) but phenotypically distinct (mottled yellow and pseudoagouti) mice as well as congeneic (a/a) black mice to evaluate immunocompetence as a function of genotype and phenotype. Mottled yellow Avy/a mice, which are fat and have increased susceptibility to neoplasia, presented an immunologic profile characterized by decreased antibody response to the T-cell-dependent immunogen tetanus toxoid, enhanced antibody response to the T-cell-independent immunogen type III pneumococcal polysaccharide, decreased (unadjusted) rates of carbon clearance, and increased levels of serum IgA. In contrast, pseudoagouti Avy/a mice were immunologically comparable to black a/a mice. The data demonstrate that differences in phenotypic expression between genetically identical mice may significantly alter immune function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609359      PMCID: PMC345455          DOI: 10.1073/pnas.81.7.2152

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Genetic obesity and neoplasia.

Authors:  W E HESTON; G VLAHAKIS
Journal:  J Natl Cancer Inst       Date:  1962-07       Impact factor: 13.506

2.  Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice.

Authors:  G Fernandes; P Friend; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Immunologic responsiveness and the induction of experimental neoplasms.

Authors:  L W Law
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

4.  Aberrant regulation of the Agouti pigment pattern in the viable yellow mouse.

Authors:  D B Galbraith; G L Wolff
Journal:  J Hered       Date:  1974 May-Jun       Impact factor: 2.645

5.  Immunologic deficiency associated with mammary tumor virus (MTV) infection in mice: hemagglutinin response and allograft survival.

Authors:  P B Blair; M L Kripke; M A Lappé; R S Bonhag; L Young
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

6.  Immunologic studies on resistance to oncogenic agents in mice.

Authors:  O Stutman
Journal:  Natl Cancer Inst Monogr       Date:  1972-12

7.  Masking of mutant metabolic phenotypes by prenatal maternal influences.

Authors:  G L Wolff
Journal:  Prog Clin Biol Res       Date:  1982

8.  Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.

Authors:  R S Speirs; R W Benson; D W Roberts
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice.

Authors:  T T Yen; J A Allan; P L Yu; M A Acton; D V Pearson
Journal:  Biochim Biophys Acta       Date:  1976-08-23

10.  Nutritional modulation of immune responses.

Authors:  R A Good; A West; G Fernandes
Journal:  Fed Proc       Date:  1980-11
View more
  3 in total

Review 1.  Adaptive immunity and adipose tissue biology.

Authors:  Denise A Kaminski; Troy D Randall
Journal:  Trends Immunol       Date:  2010-10       Impact factor: 16.687

2.  Epigenome modulated xenobiotic detoxification pathways control DMBA-induced breast cancer in agouti Avy/a mice.

Authors:  Simbarashe Mazambani; Madeleine Morris; Venugopalan Cheriyath
Journal:  Epigenetics       Date:  2019-05-09       Impact factor: 4.528

Review 3.  Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis.

Authors:  Luisa Vonghia; Peter Michielsen; Sven Francque
Journal:  Int J Mol Sci       Date:  2013-10-01       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.